MYRIAD GENETICS, INC. Amortization of Debt Discount (Premium)
MYRIAD GENETICS, INC. (MYGN) reported Amortization of Debt Discount (Premium) of $800.00 thousand for the 3-month period ending 2016-09-30, per its 10-Q filed 2016-11-02.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2016-11-02
- MYRIAD GENETICS, INC. amortization of debt discount (premium) for the quarter ending 2016-09-30 was $800.00K.
| Period end | Amortization of Debt Discount (Premium) 3 month |
|---|---|
| 2016-09-30 | $800.00K 10-Q · filed 2016-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |